We support pharmaceutical companies in the UK with brand listings
Brand Listing Issues
Inconsistent product listings and inadequate maintenance of brands across the dm+d, GP clinical systems, pharmacy clinical systems, wholesalers and online pharmacies, can lead to various problems, including:
Confusion among prescribers and pharmacies
Reduced sales
Loss of market share to competitor products
Poor patient and healthcare professional experience
Increased potential for prescribing and dispensing errors
Negative impact on brand image
How Can Oberoi Assist?
Oberoi can support pharmaceutical companies with a full audit covering a range of stock keeping units(SKU)s.
What’s included?
A detailed report highlighting listings (and any inconsistencies) of each product SKU across:
The dm+d
GP Clinical Systems (EMIS Web, Vision and SystmOne)
Pharmacy Clinical Systems
Key Pharmacy Wholesalers
Key Online Pharmacies
Impact
Improved consistency in product listings across different systems
Enhanced brand image and reputation
Potential increase in sales by identifying and rectifying any inconsistencies
Example Project
A pharmaceutical company collaborated with Oberoi Consulting to conduct an audit of their enteral feed product brand.
During the audit, various inconsistencies were identified, and it was discovered that a major online pharmacy had stock issues that the brand team was unaware of.
Based on the findings, recommendations were provided to the client on how to resolve the inconsistencies and how to approach the stock issue in the most effective way.
As a result, this audit has been incorporated into the client’s annual brand maintenance package to ensure continued consistency and compliance.
